Document is current
Any future updates will be listed below
-
Authors
Dong, Lin
Wu, Huanwen
Li, Ning
Li, Wenbin
Song, Yan
Xiong, Yuanyuan
Yin, Huan
Fang, Huan
Chen, Rongrong
Yi, Xin
Huang, Jie
Ying, Jianming
-
Funding
Funding for this research was provided by:
Chinese Society of Clinical Oncology Beijing Xisike Clinical Oncology Research Foundation (Y-HR2019-0306)
CAMS Innovation Fund for Medical Sciences (2023-I2M-C&T-B-083)
- License Information
-
More Information
Article History
Received: 30 April 2025
Accepted: 16 September 2025
First Online: 10 October 2025
Declarations
:
: The study was approved by the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (project ID: 20/473–2669). All the procedure conformed to the principles of the Helsinki Declaration.
: Not applicable.
: Yuanyuan Xiong, Huan Yin, Huan Fang, Rongrong Chen and Xin Yi were the employees of Geneplus-Beijing, other authors declare no potential conflicts of interest.
